While this approach has yet to provide substantial benefit in GBM, combining the ICIs with the DATE and injected T cells may be worth further exploration in this setting where some of the immunosuppressive features of the GBM have been overcome by targeting CA9. Here, CA9 is linked to glioblastoma.